Ketamine Withdrawn Phase 2 Trials for Traumatic Brain Injury (TBI) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00556387Efficacy of Ketamine in Children With Severe Brain Injury for Brain Cell Protection